Risperidone in the treatment of psychotic-like and deficit symptoms of schizotypal personality disorder
Phase of Trial: Phase II
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Risperidone (Primary)
- Indications Personality disorders
- Focus Therapeutic Use
- 02 Aug 2016 Status changed from active, no longer recruiting to completed.
- 27 Nov 2005 New trial record.